Intravenous acetaminophen for the management of short-term post-operative pain a review of clinical effectiveness and cost-effectiveness
Given its potential demand for use, particularly for immediate post-operative pain, there is a need to demonstrate whether the addition of intravenous (IV) acetaminophen to the multimodal pain pathway for adult patients requiring post-operative analgesia would be clinically as well as cost-effective...
| Main Authors: | , |
|---|---|
| Corporate Author: | |
| Format: | eBook |
| Language: | English |
| Published: |
Ottawa (ON)
CADTH
2018, October 12, 2018
|
| Edition: | Version 1.0 |
| Series: | CADTH rapid response report: summary with critical appraisal
|
| Subjects: | |
| Online Access: | |
| Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
| Summary: | Given its potential demand for use, particularly for immediate post-operative pain, there is a need to demonstrate whether the addition of intravenous (IV) acetaminophen to the multimodal pain pathway for adult patients requiring post-operative analgesia would be clinically as well as cost-effective. This report was undertaken to examine the current evidence surrounding the clinical and cost-effectiveness of IV acetaminophen in order to inform decision-makers on whether there is value in wider adoption of this product for local use |
|---|---|
| Physical Description: | 1 PDF file (36 pages) illustrations |